Gene · 6921
Papers1,693
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,693
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The CUL5 E3 ligase complex negatively regulates central signaling pathways in CD8+ T cells. | Nat Commun | 2024 | 38242867 | PubTator, text mining | PubMed |
| A computational exploration of global and temporal dynamics of selection pressure on HIV-1 Vif polymorphism. | Virus Res | 2024 | 38237808 | PubTator, text mining | PubMed |
| ARMC5 controls the degradation of most Pol II subunits, and ARMC5 mutation increases neural tube defect risks in mice and humans. | Genome Biol | 2024 | 38225631 | PubTator, text mining | PubMed |
| Identification of potential biomarkers and therapeutic targets related to post-traumatic stress disorder due to traumatic brain injury. | Eur J Med Res | 2024 | 38212778 | PubTator, text mining | PubMed |
| Co-opting the E3 ligase KLHDC2 for targeted protein degradation by small molecules. | Nat Struct Mol Biol | 2024 | 38177675 | Swiss-Prot, curated | PubMed |
| Cullin5 drives experimental asthma exacerbations by modulating alveolar macrophage antiviral immunity. | Nat Commun | 2024 | 38177117 | PubTator, text mining | PubMed |
| Direct inhibition of human APOBEC3 deaminases by HIV-1 Vif independent of the proteolysis pathway. | Biophys J | 2024 | 38115583 | PubTator, text mining | PubMed |
| Mutated ASXL1 upregulates mTOR expression in renal cell carcinoma with fibromyomatous stroma. | Virchows Arch | 2024 | 38102390 | PubTator, text mining | PubMed |
| Genomic alterations and diagnosis of renal cancer. | Virchows Arch | 2024 | 37999735 | PubTator, text mining | PubMed |
| Genetic variants in hypoxia-inducible factor pathway are associated with colorectal cancer risk and immune infiltration. | J Cell Mol Med | 2024 | 37994607 | PubTator, text mining | PubMed |
| Computational analysis of protein-protein interactions of cancer drivers in renal cell carcinoma. | FEBS Open Bio | 2024 | 37964489 | PubTator, text mining | PubMed |
| Characterizing and predicting ccRCC-causing missense mutations in Von Hippel-Lindau disease. | Hum Mol Genet | 2024 | 37883464 | PubTator, text mining | PubMed |
| Decreased Local Specialization of Brain Structural Networks Associated with Cognitive Dysfuntion Revealed by Probabilistic Diffusion Tractography for Different Cerebral Small Vessel Disease Burdens. | Mol Neurobiol | 2024 | 37606718 | PubTator, text mining | PubMed |
| CRISPR screens in iPSC-derived neurons reveal principles of tau proteostasis. | bioRxiv | 2024 | 37398204 | PubTator, text mining | PubMed |
| Predicting the Structural Impact of Human Alternative Splicing. | bioRxiv | 2023 | 38187531 | PubTator, text mining | PubMed |
| PRAME Expression: A Target for Cancer Immunotherapy and a Prognostic Factor in Uveal Melanoma. | Invest Ophthalmol Vis Sci | 2023 | 38149971 | PubTator, text mining | PubMed |
| Identification of Adenovirus E1B-55K Interaction Partners through a Common Binding Motif. | Viruses | 2023 | 38140597 | PubTator, text mining | PubMed |
| Association of aberrant structural-functional network coupling with cognitive decline in patients with non-dialysis-dependent stage 5 chronic kidney disease. | Quant Imaging Med Surg | 2023 | 38106236 | PubTator, text mining | PubMed |
| Whole genome sequencing refines stratification and therapy of patients with clear cell renal cell carcinoma. | Res Sq | 2023 | 38106039 | PubTator, text mining | PubMed |
| The role of HIF in angiogenesis, lymphangiogenesis, and tumor microenvironment in urological cancers. | Mol Biol Rep | 2023 | 38085375 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6921/papers?page=5